Company / Depreciation & Amortization
InMed Pharmaceuticals Inc. Depreciation & Amortization History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$219.6K
FY2025
5-year range
$120.9K / $219.6K
FY2022-FY2025
Trend
+8.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Depreciation & Amortization has increased for 3 consecutive years, from $120,866 in FY2022 to $219,600 in FY2025.
Based on SEC 10-K filings.
$219,600 in FY2025 with a 3-year CAGR of +22.0%.
Increased from $185,657 to $219,600 over the past 2 years.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- +22.0%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- InMed Pharmaceuticals Inc.'s depreciation & amortization has grown for 3 consecutive years.
- 3-year CAGR of +22.0%, indicating consistent growth.
- In FY2025, depreciation & amortization increased 8.6% year-over-year.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $219.6K | +8.6% |
| FY2024 | $202.2K | +8.9% |
| FY2023 | $185.7K | +53.6% |
| FY2022 | $120.9K | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026